News FocusCancer Research

After Regime Change at the National Cancer Institute

See allHide authors and affiliations

Science  21 Apr 2006:
Vol. 312, Issue 5772, pp. 357-359
DOI: 10.1126/science.312.5772.357

You are currently viewing the summary.

View Full Text


Andrew von Eschenbach, who has been nominated to head the Food and Drug Administration, is expected to step down soon as director of NCI after a controversial tenure. His successor will face a big budget squeeze and low morale. (Read more.)